AVENTIS PHARMA DEUTSCHLAND GMBH (AVENTIS PHARMA)
Patent Owner
Stats
- 70 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jul 10, 2007 most recent publication
Details
- 70 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,390 Total Citation Count
- Jan 11, 1979 Earliest Filing
- 51 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
7071222 Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and N-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amideMar 07, 97Jul 04, 06[A61K]
6610299 Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugatesOct 19, 94Aug 26, 03[A61K]
6455551 Use of 1-hydroxy-2-pyridones for treating mucosa diseases which are difficult to treatJun 03, 98Sep 24, 02[A61K, C07D]
6335467 Substituted benzenesulfonylureas and thioureas-process for their preparation and their use as pharmaceuticalsJan 24, 00Jan 01, 02[C07C]
6121479 Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnosticsApr 22, 99Sep 19, 00[C07C]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
7241595 Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugatesExpiredApr 24, 02Jul 10, 07[C12P]
6475486 Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugatesExpiredJun 30, 99Nov 05, 02[A61K]
6420546 Oligoribonucleotide and ribozyme analogs with terminal 3'--3' and/or 5'--5' linkagesExpiredApr 14, 98Jul 16, 02[C07H, C12Q, A01N]
6369057 Quinoxalines, processes for their preparation and their useExpiredApr 07, 95Apr 09, 02[A61K, C07D]
6100376 A.sup.21, B.sup.30, modified insulin derivatives having an altered action profileExpiredApr 16, 97Aug 08, 00[A61K]
6074650 Membrane anchor/active compound conjugate, its preparation and its usesExpiredJun 06, 95Jun 13, 00[A61K]
6063571 Process for amplifying nucleic acids using DNA/PNA primersExpiredSep 11, 97May 16, 00[C12Q, C12P]
5747504 Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitorsExpiredSep 06, 96May 05, 98[A61K]
5723461 Quinoxalines, a process for their preparation and their useExpiredOct 17, 95Mar 03, 98[A61K, C07D]
5700910 N-acyl-S-(2-hydroxyalkyl) cysteines, their preparation and their use as intermediates for the preparation of synthetic immuno-adjuvants and synthetic vaccinesExpiredJun 07, 95Dec 23, 97[C07C, C07K]
5679583 Monoclonal antibodies for the selective immunological determination of intact procollagen peptide (type III) and procollagen (type III) in body fluidsExpiredApr 05, 95Oct 21, 97[C12N, G01N, C07K]
5278152 2-formylbenzylphosphonic acid derivatives useful for the treatment of diseases caused by virusesExpiredFeb 18, 93Jan 11, 94[A61K, C07F]
5231083 Method for the treatment of cardiac and of vascular hypertrophy and hyperplasiaExpiredAug 09, 90Jul 27, 93[A61K]
5175306 Process for the resolution of racemates of optically active bicyclic imino-.alpha.-carboxylic estersExpiredAug 03, 90Dec 29, 92[C07D]
5166346 Process for the preparation of thiophene derivatives and also new dihydrothiophene 1-oxidesExpiredDec 20, 90Nov 24, 92[C07D]
5151433 Stabilized medicinal substances, a process for the preparation thereof, and stable medicinal formulationsExpiredNov 22, 88Sep 29, 92[A61K, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.